Back to Annual Meeting Page
|
133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA |
||
3117.0: Monday, December 12, 2005: 10:30 AM-12:00 PM | |||
Oral | |||
| |||
This session on pharmaceuticals is comprised of diverse presentations, ranging from equitable drug distribution during macroeconomic crises, to the function of an essential drug list in improving rational drug use, to the public health implications of poor quality medicines or non-adherence to drug regimens. Specifically, the presentations will discuss: (1) a program for equitable distribution of medicines to low-income populations during Argentina's economic crisis; (2) abuse of western pharmaceuticals and the implications for antimicrobial resistance, using Nigeria as a case study; (3) the role of an essential drug list in Palestine in evaluating drug utilization and improving rational drug use; (4) the public effect of poor quality medicine on development of antimicrobial resistance, and potential strategies to reduce dangers of counterfeit or substandard drugs and (5) the importance of a rational drug strategy and appropriate role of the pharmaceutical sector in protecting public health in Jordan. | |||
Learning Objectives: At the conclusion of this session, the participant will be able to (1) recognize impact of irrational drug use and substandard quality drugs on public health and (2) understand the characteristics and role of essential drug lists in health policy. | |||
Kama Garrison, MPH | |||
Introductory Remarks | |||
West is best : Abuse of western pharmaceuticals in Eastern Nigeria and it's effect on anti-microbial resistance Ngozi Ogbuawa, M Sc | |||
Estimating the cost savings and rational use effects of implementing an essential drug list in West Bank, Palestine Samer Hamidi, M. Mahmud Khan, PhD, Doreen Babo, Richard Culbertson, PhD, Janet Rice, PhD, Mustafa (Mike) Younis, DrPH | |||
Counterfeit and poor quality medicines: An overlooked threat to health Nancy L. Blum, MPH, MA, Souly Phanouvong, PhD | |||
Improving the Use of Pharmaceuticals in Jordan: The Importance of Pharmaceutical care and a Rational Drug Strategy Dima Qato, PharmD, MPH, Maggie Huff-Rousselle, MA, MBA | |||
Concluding Remarks | |||
See individual abstracts for presenting author's disclosure statement and author's information. | |||
Organized by: | International Health | ||
Endorsed by: | Public Health Nursing | ||
CE Credits: | CME, Health Education (CHES), Nursing |
The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA